Clinical Trial Update: Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023 [Phase 1]

View source ↗

Summary

Phase 1 single-ascending-dose and multiple-ascending-dose safety and pharmacokinetic study of KM-023 in HIV patients has completed. No efficacy results are repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• KM-023

Snippet

Sponsor: Kainos Medicine Inc. | Conditions: Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED